1 filter applied. Clear filter
White Paper
Supporting Evidence Generation of Indirect Benefits and Risks for Medical Products Used for Infectious Diseases
Brian Canter, Nancy Allen LaPointe, Sabine Sussman, Mark McClellan
2025
Read MoreWhite Paper
Integrating Indirect Health Benefits into Biomedical Policy: Key Reforms for Federal Agencies to Reduce Disease Transmission
Sabine Sussman, Brian Canter, Mark McClellan
2025
Read MoreWhite Paper
Operational Tools and Best Practices to Support Electronic Health Record-Sourced Data Quality, Relevance, and Reliability at the Data Accrual Phase
Matt D'Ambrosio, Patrick Rodriguez, Nora Emmott, Rachele Hendricks-Sturrup
2025
Read MoreWhite Paper
Building a Resilient and Secure Pharmaceutical Supply Chain: The Role of Geographic Diversification
Thomas Roades, Cameron Joyce, Madi Cordle, Katherine Hamilton, Gerrit Hamre, Mark McClellan
2024
Read More